- Posts by Bradley Merrill Thompson
Member of the FirmAttorney Brad Thompson counsels medical device, drug, and combination product companies on a wide range of FDA and FTC regulatory, reimbursement, and clinical trial issues.
Machine Learning and Artificial Intelligence Practice
Blogs
2 minute read
Advances in artificial intelligence (“AI”) continue to present exciting opportunities to transform decision-making and targeted marketing within the world of consumer products. While AI has been touted for its capabilities in creating fairer, more inclusive systems, including with respect to lending and creditworthiness, AI models can also embed human and societal biases in a way that can result in unintended, and potentially unlawful, downstream effects.
Mostly when we talk about bias, we focus on accidental bias. What about intentional bias? The following ...
Blog Editors
Recent Updates
- Even Privilege Logs Can Be Privileged Under the Fifth Amendment
- “Claims” Under the FCA, §1983 Claim Denials on Failure-to-Exhaust Grounds, and Limits to FSIA’s Expropriation Exception - SCOTUS Today
- The 340B Reimbursement Battle: What Hospitals and Insurers Need to Know
- A Ticking Time Bomb—Universal Injunctive Relief at Risk - SCOTUS Today
- CFPB’s Recent Rule Eliminates Medical Debt from Credit Reports